发明名称 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF VEGF EXPRESSION
摘要 The present invention relates to an oligonucleotide or a derivative thereof which has a sequence that corresponds to a part of a nucleic acid which encodes VEGF (vascular endothelial growth factor) and which has the ability to inhibit tumor growth in animal tumor models, the invention further relates to the preparation of such oligonucleotide and the use thereof. An oligonucleotide or a derivative thereof which has the sequence SEQ ID NO. 4 or a part thereof, wherein SEQ ID NO. 4 is 3'-GTACCTACAGATAGTCGCGTCGATGACGGTAGG-5 @ , with the first proviso, that not all internucleoside bridges in the oligonucleotide are phosphodiester internucleoside bridges and not all phosphodiester internucleoside bridges are replaced by phosphorothioate internucleoside bridges and/or the second proviso, that the oligonucleotide contains no modified nucleosides selected from C5-propynyl uridine, C5-propynyl cytidine, C5-hexynyl uridine, C5-hexynyl cytidine, 6-aza uridine and 6-aza cytidine.
申请公布号 HU0103290(A2) 申请公布日期 2001.12.28
申请号 HU20010003290 申请日期 1999.07.29
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH. 发明人 BITONTI ALAN;PEYMAN ANUSCHIRWAN;UHLMANN EUGEN;WOESSNER RICHARD
分类号 C12N15/09;A61K31/70;A61K31/7088;A61K38/00;A61K48/00;A61P9/00;A61P13/12;A61P17/06;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07H21/00;C07H21/04;C12N15/113 主分类号 C12N15/09
代理机构 代理人
主权项
地址